Please login to the form below

Not currently logged in
Email:
Password:

Budget supports Pharma

The pharmaceutical industry in the UK is set to benefit from proposals announced by Chancellor Alistair Darling in this year's Budget

The pharmaceutical industry in the UK is set to benefit from proposals announced by Chancellor Alistair Darling in this year's Budget.

Under the heading of tax and innovation, Darling's Budget contains a proposal which aims to identify any changes to the current system that will encourage innovative industries such as pharma and increase the attractiveness of the UK as a destination for R&D activities. "Working with representatives across the business community, the government will examine the balance of taxation of innovative activity, including intellectual property," the report says.

Commenting on the proposals within the Budget, Dr Richard Barker, director-general of The Association of the British Pharmaceutical Industry (ABPI), said: "The announcement of this consultation demonstrates the commitment of the UK government to life sciences in Britain and represents an important first achievement for the Office for Life Sciences. It could have significant impact on how companies make their investment decisions."

Following the consultation on tax changes, the government will deliver its assessment prior to publication of the Pre-Budget Report in November 2009. 

22nd April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics